Patent License Grant. 2.1 Caltech hereby grants to Licensee an exclusive, royalty-bearing, worldwide license, with the right to grant and authorize sublicenses, under the Licensed Patents and Technology to make, have made, use, import, offer for sale and sell Licensed Products, practice any method or procedure and otherwise exploit the Licensed Patents and Technology.
2.2 These licenses are subject to: (a) the reservation of Caltech’s right to make, have made, and use Licensed Products for noncommercial educational and research purposes, but not for sale or other distribution to third parties; and (b) the rights of the U.S. Government under Txxxx 00, Xxxxxx Xxxxxx Code, Section 200 et seq., including but not limited to the grant to the U.S. government of a nonexclusive, nontransferrable, irrevocable, paid-up license to practice or have practiced any invention conceived or first actually reduced to practice in the performance of work for or on behalf of the U.S. Government throughout the world. These licenses are not transferable by Licensee except as provided in Section 16.4, but Licensee shall have the right to grant non-exclusive or exclusive sublicenses hereunder, provided that:
(a) License shall include all its sublicensing income in Licensee’s reports to Caltech, as provided in Section 9.2, and Licensee shall pay royalties thereon to Caltech pursuant to Section 4.2 and 4.4;
(b) Licensee shall furnish Caltech within thirty (30) days of the execution thereof, a true and complete copy of each sublicense and any changes or additions thereto;
(c) License may grant sublicenses of no greater scope than the license granted under Section 2.1; and Each sublicense granted by Licensee shall include provisions similar in all material respects to those of Articles 6, 12, 15, 16 and Section 2.2.
Patent License Grant. Licensor hereby grants to Licensee a worldwide, exclusive (without any reservation of rights by Licensor) license under the Licensed Patents during the term of this Agreement, to: (i) use, develop, make, have made, sell, offer to sell, import, export, lease, or otherwise dispose of any Licensed Product; (ii) use any method or process in manufacturing the Licensed Products; (iii) use and perform any Licensed Processes; and (iv) to otherwise practice the claimed inventions pertaining to RQ-00000005 Technology in the Licensee Field of Use.
Patent License Grant. 17.1 On the terms and subject to the conditions set forth herein, Palomar hereby grants to Coherent a non-exclusive, royalty-bearing sublicense (without the right to sublicense others) under the Palomar Patents to make, have made, use and sell Distributed Products and competitive Coherent products for which royalties are paid to Palomar under Section 16.4 ("Coherent Products") in the Territory during the License Term. For Distributed Products manufactured by Palomar and sold by Coherent, Palomar shall be solely responsible for paying all royalty obligations to MGH relating to the Xxxxxxxx Patent that may arise as a result of the manufacture, use or sale of Distributed Products during the License Term. Licensed Products manufactured by Coherent shall bear a royalty of * of Net Revenues. During the term of this Agreement, such royalty obligations shall be fulfilled by payment to Palomar of the amounts set forth in Section 16.
17.2 All rights not expressly granted are reserved to Palomar. Nothing herein shall be construed as granting Coherent, by implication, estoppel or otherwise, including the first sale doctrine, any license or other right under any patent or other intellectual property right of Palomar, except for the licenses expressly granted in Section 17.
17.3 Upon termination of this Agreement, Palomar agrees to grant Coherent any licenses required for Distributed Products distributed by Coherent pursuant to this Agreement to any other patents it licenses or owns, on commercially reasonable terms to be negotiated. The parties shall negotiate in good faith, but no license shall be granted if the parties are unable to reach agreement on reasonable terms.
17.4 In addition to the license granted under Section 17.1 above, from and after the termination date of this Agreement, Palomar hereby grants Coherent a non-exclusive, worldwide, royalty-bearing license in the License Field to make, have made, use and sell Licensed Products that infringe the Xxxxxxxx Patent. The sublicense shall include the right to grant to the purchasers of Licensed Products from Coherent and its Affiliates, the right to use such Licensed Products in a method coming within the scope of the Xxxxxxxx Patent. Coherent shall have no right to grant further sublicenses to the Xxxxxxxx Patent, except that it shall be permitted to transfer its rights in connection with the sale of its hair removal product line.
17.4.1 After termination of this Agreement, and in no event less than three year...
Patent License Grant. 2.1 Caltech hereby grants to Licensee:
(a) a worldwide, exclusive royalty-bearing license within the Field under Licensed Patent Rights to make, have made, import, have imported, sublicense, have sublicensed, use, have used, sell, and have sold Licensed Products and Licensed Services; and
(b) a worldwide, nonexclusive royalty-bearing license to the Technology for the development of Licensed Products and Caltech agrees that it will not provide any third party rights to Technology that would allow such third party to commercially develop Licensed Products in a jurisdiction for which licensee is paying royalties under 3.2.
Patent License Grant. Licensor hereby grants and agrees to grant to Licensee the exclusive license, including the right to sublicense pursuant to the terms of Section 4.3 hereof, in the Territory and in the Field, in, to and under all of Licensor's right, title and interest to and under the Patents and Patent Rights, to import, to use, to offer for sale, and to sell, modify, have modified, market, and distribute directly or indirectly and through multiple channels of distribution, the Products and Combined Products and to have those rights exercised on its behalf, during the Term and subject to the provisions of this License Agreement.
Patent License Grant. 2.1 Grant of License to DOW - Subject to the terms and conditions of this License, DIVERSA hereby grants to DOW, and DOW hereby accepts: (a) an a exclusive, royalty-bearing, worldwide license, including the right to grant sublicenses pursuant to Section 2.4, under the DIVERSA Patent Rights and Joint Patent Rights to make, have made, import, have imported, use, have used, sell, have sold and otherwise exploit Royalty Bearing Products; (b) an exclusive, world-wide license, including the right to grant sublicenses pursuant to Section 2.4, under DIVERSA's enzymes [****] to use enzymes to convert Research Target(s) into products via Research Target Processes (Research Target and Research Target Processes are defined as in the Agreement). The royalty for this grant is obtained by DIVERSA under (a); (c) a non-exclusive, royalty-bearing, world-wide license to [****] and (d) a royalty-free license to any Know-How required to exploit the rights granted under (a), (b), and (c), and for DOW or its Affiliates to perform research on any Improved Enzyme.
Patent License Grant. AMTRUST hereby grants to NATIONAL GENERAL, and NATIONAL GENERAL hereby accepts, a worldwide, non-exclusive, royalty-free, fully paid-up, perpetual, sublicensable (subject only to Section 6(b) below) and assignable (subject only to Section 6(c) below) license in, to and under The ‘861 Patent Rights (the “Patent License”), to be exercised on an internal basis only, solely in connection with and as necessary to operate the NPS System, including, without limitation, any Future NPS System.
Patent License Grant. Licensor hereby grants to IMPERIAL the exclusive right, privilege and license within the territorial limits of Canada, to (i) practice, use and exploit the Intellectual Property; (ii) incorporate the Intellectual Property into processes, methods, and products necessary or convenient for IMPERIAL’s business. The parties acknowledge and agree that the consideration for the grant of the license provided in this Agreement is sufficient consideration for the license granted in this Agreement, and that no separate consideration is required for any such license granted in this Agreement. Intellectual property shall include all the patents, pending patent applications, continuations, continuations-in-part, licenses held by Licensor and any future patent applications, or process technology owned or developed by Licensor and useful in the recovery of bitumen and oil from oil and tar sands and limestone rock asphalt.
Patent License Grant. Subject to the terms of this Agreement, Company grants to Distributor an exclusive license under the Patents to make, use, sell, and offer for sale the Product within the Patent Territory.
Patent License Grant. 7. CALTECH hereby grants to CMS and any Related Company an exclusive license to make, have made, use, distribute and sell Licensed Products throughout the world, subject to the reservation of CALTECH’s right, on the part of itself and the Jet Propulsion Laboratory, to make, have made, and use Licensed Products solely for educational and research purposes. This license is not transferable by CMS, but CMS shall have the right to grant sublicenses provided that:
(A) In the event CMS receives any licensing fees or royalty payments from the sublicensing by CMS of this Agreement including running royalty payments from its sublicensees, CALTECH shall receive ***% of all such fees or payments.
(B) CMS shall furnish CALTECH within thirty (30) days of the execution thereof, a true and complete copy of each sublicense and any changes or additions thereto.
(C) In the event that CALTECH terminates this License Agreement because of a material breach by CMS which is not cured by CMS within the time specified in Article VI *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filed separately with the Commission. then CALTECH shall offer Molecular Dynamics a license ssubstantially identical to the sublicense to be negotiated between CMS and Molecular Dynamics.
8. The exclusive patent license shall continue until the last of the Licensed Patents expires.
